
11 - 50 employees
🏥 Healthcare
💼 Consulting
🍽️ Food & Beverage
Healthcare • Consulting • Food & Beverage
Pulmovant is a company committed to transforming the lives of patients with pulmonary diseases by developing innovative therapies. Their lead product, mosliciguat, aims to provide a once-daily, inhaled treatment for pulmonary hypertension, distinguished by its novel sGC activation mechanism. With a singular focus on addressing the unique needs of patients suffering from pulmonary conditions, Pulmovant is engaged in extensive clinical trials to advance its pioneering treatment options.
📡 We watch Pulmovant's careers page
Every 2 hours
how often we check
2
roles posted in the last 30 days
About 34 days
usual time to fill a role
20
roles closed in the last year
Selected: 🆕 Date Added.
🕒 6 days ago
Senior Clinical Database Programmer overseeing Veeva CDMS and DQS builds, transfers, validation, and data reconciliation. Supporting Pulmovant’s Phase 3 pulmonary disease trials.
🇺🇸 United States – Remote
💵 Estimated: $78k - $111k / year
⏰ Full Time
🟠 Senior
🖥 Software Engineer
👻 Ghost score 22%
🕒 November 11
Executive Assistant supporting Pulmovant’s senior clinical biotech leaders. Managing calendars, travel, events, expenses, and confidential administrative operations for a growing clinical-stage company.
🇺🇸 United States – Remote
💵 Estimated: $78k - $107k / year
⏰ Full Time
🟠 Senior
👨💼 Executive Assistant
👻 Ghost score 22%
🕒 October 14
Head of Analytical Development leading Pulmovant’s analytical strategy for inhaled pulmonary hypertension therapies. Overseeing drug substance, drug product, regulatory submissions, CDMOs, and commercial launch readiness.
🕒 October 14
Associate Director leading inhaled dry powder drug product development at Pulmovant, a pulmonary biotechnology company. Driving CDMO manufacturing, CMC submissions, validation, and commercial readiness.
🇺🇸 United States – Remote
💵 Estimated: $208k - $260k / year
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 23%
🕒 October 9
CMC project manager advancing Pulmovant’s inhaled mosliciguat treatment for pulmonary hypertension through Phase 3. Coordinating timelines, vendors, budgets and regulatory deliverables.
🇺🇸 United States – Remote
💵 Estimated: $122k - $160k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
👷♀️ Project Manager
👻 Ghost score 25%
🕒 September 28
Statistical programming manager advancing Pulmovant’s pulmonary disease clinical trials. Delivering SAS/R datasets, TLFs, and regulatory submissions.
🇺🇸 United States – Remote
💵 Estimated: $152k - $186k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
👔 Manager
👻 Ghost score 28%
🕒 September 25
Senior Regulatory Affairs leader guiding Pulmovant’s mosliciguat, an inhaled pulmonary hypertension therapy, through global clinical development and approval. Shaping FDA and international submission strategy.
🇺🇸 United States – Remote
💵 Estimated: $198k - $249k / year
⏰ Full Time
🔴 Lead
🚔 Compliance
👻 Ghost score 29%
🕒 September 24
Associate Director leading drug substance process development, scale-up, and CDMO tech transfer. Advancing Pulmovant’s inhaled pulmonary hypertension therapy toward Phase 3 and commercial manufacturing.
🇺🇸 United States – Remote
💵 Estimated: $196k - $240k / year
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Director
👻 Ghost score 30%
🕒 September 23
Director of Biostatistics leading statistical strategy for Pulmovant’s Phase 3 PH-ILD trial. Driving regulatory-ready analyses for its inhaled mosliciguat treatment.
🇺🇸 United States – Remote
💵 Estimated: $218k - $267k / year
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Director
👻 Ghost score 30%
🕒 September 22
Clinical Development Lead guiding mosliciguat’s Phase 3 pulmonary hypertension trial at Pulmovant. Providing medical oversight, protocol leadership, and regulatory collaboration for pulmonary disease treatments.
🇺🇸 United States – Remote
💵 Estimated: $124k - $198k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
👻 Ghost score 30%